We invest in Iran and Iran related biotechnology and pharmaceutical companies with exceptional technologies or product opportunities based on strong scientific rationale and commercial potential.

1. Our key asset is a unique team of nearly 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide our portfolio companies with hands-on guidance and support.
2. We provide our portfolio companies with the necessary resources for long-term sustainable growth. We provide them with access to network, executive talent, strategic, operational, and business development resources.
3. This approach enhances their value and the investor’s long-term capital appreciation, while strengthening Iran’s Biotech industry which increases investment opportunities.